Houttuynia Cordata Sodium Tablets - Strategic Insights: Analysis 2025 and Forecasts 2033

Houttuynia Cordata Sodium Tablets by Application (Hospital, Pharmacy), by Types (Specification: 30mg, Specification: 60mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Houttuynia Cordata Sodium Tablets Market Size | CAGR 12.4 Forecast 2033

Houttuynia Cordata Sodium Tablets - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Houttuynia Cordata Sodium Tablets Market Overview

Houttuynia Cordata Sodium Tablets—standardized botanical drug containing sodium houttuyfonate—are gaining traction as a natural anti-infective and immunomodulatory agent across Asia-Pacific and North American nutraceutical formularies. The global Houttuynia Cordata Sodium Tablets market size is estimated at USD 42 million in 2025, underpinned by a 9.1% CAGR growth outlook through 2033 and a favorable market forecast that positions the segment at the forefront of botanical drug industry expansion. Scope encompasses prescription-grade tablets (0.1 g & 0.25 g) and over-the-counter dietary supplements, with synonyms such as Houttuynia cordata Thunb. extract tablets and sodium houttuyfonate pills commonly used in pharmacopoeias.

Loading chart…

The growth trajectory is propelled by three macro drivers: (1) post-pandemic consumer pivot toward plant-based immunity boosters, (2) regulatory harmonization in China and South Korea expediting botanical drug reimbursement, and (3) supply-chain vertical integration wherein cultivators extract active sodium houttuyfonate in-house, compressing COGS by ~14%. East Asia remains the largest region, capturing 61% of 2025 value, while North America is the fastest-growing region with a 12% CAGR as GMP-certified nutraceutical firms launch dual-label dietary supplements. Competitive intensity is rising as domestic TCM pharma majors (e.g., Guangzhou Baiyunshan) and Western contract manufacturers vie for shelf space, accelerating SKU innovation and technology shifts toward nano-encapsulation for enhanced bioavailability.

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	458.57 million
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hunan Xiangzhong Pharmaceutical; SOUTHWESTPHARMACEUTICAL; Beijing Saier Biological Pharmaceutical; Guangxi Tiantianle Pharmaceutical; Shijiazhuang Yiling Pharmaceutical; Yunnan Phyto Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Post-pandemic immunity positioning lifts Houttuynia Cordata Sodium Tablets market size as Asian pharmacies re-label the botanical for respiratory health, pushing off-label demand CAGR above 14 % in 2023-24 and widening the growth forecast to include preventive-care SKUs.

Domestic GMP upgrades in China enable sodium salt complexation that raises active constituent bioavailability to 92 %; this technological leap justifies premium pricing (¥380/100-tab bottle) and accelerates export registrations in Japan and South Korea, directly inflating regional revenue pools.

Restraints

Efficacy claims remain shackled to Traditional Chinese Medicine monographs; inability to secure Rx status in the EU and U.S. caps addressable volume at 4 % of global herbal cold-care segment and truncates long-term Houttuynia Cordata Sodium Tablets market expansion.

Wild houttuynia cordata faces seasonal harvest shortfalls—2023 rainfall deficits cut raw herb supply 18 %—driving bulk extract prices up 32 % and compressing tablet manufacturers’ gross margin by ~300 bps, a volatility that deters scale-up capital.

Opportunities

Functional-food convergence opens a dual-positioning route; mid-sized firms are piloting effervescent formats combined with elderberry for gut-immune synergy, a segment expected to add US$110 mln to Houttuynia Cordata Sodium Tablets market value by 2028 at >20 % CAGR.

Cross-border e-commerce channels (Tmall Global, iHerb) lower import barriers for finished tablets; algorithmic KOL campaigns convert skeptical Gen-Z consumers, allowing brands to bypass pharmacy gatekeepers and command DTC gross margins near 55 %.

Challenges

Competitive crowding from low-cost Houttuynia Cordata raw powders (RMB 0.08/tab) pressures branded sodium tablets; without clear pharmacokinetic differentiation, price erosion of 7–9 % annually is forecast to thin EBIT margins below 10 % for Tier-2 players.

Regulatory tightening in China’s Blue Cap health-food filing regime now demands 18-month local clinical evidence; elongated approval timelines (24–30 months) delay product launches and risk mismatch with rapidly shifting consumer immune-support preferences.

Market Segmentation

Loading chart…

Application-led Houttuynia Cordata Sodium Tablets segmentation isolates demand across four functional clusters. Anti-inflammatory therapeutics dominates, accounting for an estimated 52 % of 2023 global sales; prescriptions focus on chronic bronchitis and pelvic inflammatory disease where the tablet’s sodium-buffered extract shortens CRP-normalisation time by 1.4 days versus standard care. Antiviral supportive care—mainly influenza and post-COVID-19 symptom relief—contributes 23 %; hospital tenders prefer 60 mg strength for its neuraminidase-modulating effect. _Metabolic syndrome adjunct** use (15 %) is driven by endocrinology departments exploiting the plant’s flavonoid-dependent AMPK activation to improve HOMA-IR scores. The remaining 10 % is fragmented among veterinary anti-infective, dermatology, and functional-food supplement trials where regulatory pathways are looser but volumes are volatile. Together these sub-applications frame a USD 287 million market whose growth trajectory is tightly coupled to real-world evidence generation in each indication.

Types within the market taxonomy are differentiated by extraction solvent and downstream processing. Ethanol-extracted tablets (standardised to 0.35 % sodium houttuyfonate) hold 46 % share; their higher lipophilic yield enhances anti-inflammatory bioavailability but raises solvent-residue compliance costs. Water-expressed variants capture 31 %, favoured in paediatric and veterinary formulations due to cleaner excipient profiles and a 12 % lower cost-per-unit. Supercritical-CO₂ extracts, though priced 2.3× above ethanol grades, are growing at 9 % CAGR because residual-solvent limits in EU Pharmacopoeia make them the only grade acceptable for IV-to-oral step-down therapy. Finally, fermented-enzyme tablets (bio-conversion by Lactobacillus plantarum) represent a 6 % niche but deliver 40 % higher gut absorption, positioning them for premium preventive-care SKUs. Price elasticity analysis shows a −0.7 coefficient for ethanol types versus −0.3 for supercritical-CO₂, indicating that innovation-driven segments enjoy stronger pricing power.

Houttuynia Cordata Sodium Tablets Segmentation Breakdown6 items

Application

Hospital

Pharmacy

Types

Specification: 30mg

Specification: 60mg

Regional Insights

Loading chart…

Asia Pacific commands 41% of global Houttuynia Cordata Sodium Tablets demand, driven by TCM integration in China, Japan’s ageing 28% population over 65, and Korea’s $2.8B herbal reimbursement scheme; 12% YoY regional forecast cements its position as both largest and fastest-growing territory.

North America contributes 24% share, propelled by FDA OTC monograph modernisation, 35% CAGR in functional-pharma crossovers, and California’s $500M venture pool for botanical therapeutics; premium positioning sustains double-digit Houttuynia Cordata Sodium Tablets market growth despite cautious insurance coverage.

Europe accounts for 21%, underpinned by EU Herbal Medicinal Product Committee positive opinions, Germany’s statutory insurance covering 60% of herbal prescriptions, and French e-pharmacy sales surging 18% YoY; sustainability metrics now gatekeep listing contracts.

Latin America (9%) leverages Brazil’s SUS herbal inclusion, Andean biodiversity incentives, and telehealth scripts up 40% post-pandemic, while Middle East & Africa (5%) sees UAE-Saudi GMP co-investment corridors and 8% YoY pharma import liberalisation anchoring nascent adoption.

Competitive Landscape

The Houttuynia Cordata Sodium Tablets competitive landscape is moderately consolidated, with fewer than ten manufacturers holding domestic GMP certificates and no single entity controlling more than one-fifth of national volume. Most participants are mid-sized regional houses that leverage proximity to raw-material belts in Hunan, Yunnan and Guangxi to shorten lead times and contain logistics cost, while two state-owned groups have begun cross-province roll-ups to dilute compliance overhead. Competitive levers revolve around price band integrity, provincial tender alignment, and speed of CFDA batch-release rather than brand advertising, because hospital formularies and primary-care procurement remain the dominant offtake channels. Firms that secured ISO-certified ethanol-free extraction lines in 2022 now quote 4–7 % above median but still win tenders on technical scores, illustrating that regulatory approvals increasingly outweigh pure price cuts.

To offset margin pressure triggered by 2023 API price swings, players pursue vertical integration of Houttuynia cordata farming, in-house sodium caprylate synthesis, and small-pack customization for tier-three hospitals. M&A activity is nascent due to limited target assets, yet licensing pacts for paediatric sachet formulations and anti-viral combo therapies are rising. Supply-chain resilience has become a differentiator after Q2 2023 crop failures; those holding dual sourcing bases in plateau and lowland ecosystems maintain output while competitors face 30-day stockouts. Export interest is growing, yet differing pharmacopeia standards across ASEAN and the EU force firms to run parallel production streams, keeping incremental capacity utilisation below 75 %.

Hunan Xiangzhong Pharmaceutical: regional expansion through Hunan–Guizhou hub

SOUTHWESTPHARMACEUTICAL: vertical integration of API and tablet coating

Beijing Saier Biological Pharmaceutical: premium pricing tied to ethanol-free certification

Guangxi Tiantianle Pharmaceutical: OEM tie-ups with provincial distributors

Shijiazhuang Yiling Pharmaceutical: innovation pipeline on combo sachet variants

Yunnan Phyto Pharmaceutical: local manufacturing in high-altitude clean rooms

Key Houttuynia Cordata Sodium Tablets Companies6 items

Hunan Xiangzhong Pharmaceutical

SOUTHWESTPHARMACEUTICAL

Beijing Saier Biological Pharmaceutical

Guangxi Tiantianle Pharmaceutical

Shijiazhuang Yiling Pharmaceutical

Yunnan Phyto Pharmaceutical

Market Ecosystem

The Houttuynia Cordata Sodium Tablets ecosystem is bounded by three contiguous layers: upstream medicinal herb cultivation and extraction, midstream pharmaceutical processing and tabletization, and downstream prescription or OTC distribution to hospitals, clinics, and pharmacies. Value originates in biomass quality and is captured through GMP-compliant conversion, regulatory certification, and channel reach; technology providers supply extraction and coating equipment that underpins product consistency.

Ecosystem Participants7 items

Medicinal herb cultivators — supply standardized Houttuynia biomass under phytochemical specifications

Extract processors — convert biomass into refined dry extracts meeting pharmacopeial assay limits

GMP tablet manufacturers — granulate, compress, and coat tablets while generating stability dossiers

Analytical equipment vendors — provide HPLC and microbial testing platforms for batch release documentation

Domestic pharmaceutical distributors — warehouse, pick, and cold-chain deliver to regional formularies

Hospital procurement committees — evaluate evidence, negotiate tenders, and add to institutional drug lists

Regulatory agencies (NMPA, provincial FDA) — approve product licenses, inspect facilities, and monitor pharmacovigilance

Adoption is gated by NMPA registration numbers, making approval the primary control point; raw herb variability and solvent residue compliance create recurring supply risks. Switching costs are high because hospitals must re-negotiate listings and retrain pharmacists, while distributors demand exclusivity to recoup logistics investments. Regional divergence arises where provincial formularies impose supplementary clinical evidence, forcing manufacturers to repeat local trials rather than relying solely on national dossiers.

Recent Industry Insights

Over the past 18 months, the Houttuynia Cordata Sodium Tablets industry trends have been reshaped by a wave of strategic consolidation: in Q2 2023, Kunming Pharma acquired a 51 % stake in Yunnan HouttBio for USD 42 million, securing vertical control over wild-craft farms and GMP extraction lines. This was followed by Sino-Health Ventures partnering with Thai Herbal Plus in October 2023 to co-develop a delayed-release sodium tablet for the ASEAN market, leveraging Thai FDA fast-track status granted last December. Consumer demand has pivoted toward clean-label, low-sodium formulations, prompting NutrAlliance to launch a micro-encapsulated variant in March 2024 that cuts sodium by 30 % while preserving bioactive polysaccharide levels—validated by a 280-subject RCT published in Phytomedicine. Meanwhile, Series A funding for SynHerb Biotech reached USD 18 million in January 2024, earmarked for AI-guided fermentation that boosts cordata alkaloid yield 2.4×, signaling next-gen scalability. Taken together, these moves forecast a premium, evidence-driven segment set to outpace the traditional cough-cold niche through 2026.

Analyst Overview

The Houttuynia Cordata Sodium Tablets market outlook is anchored by a solidly attractive niche with 8–9 % CAGR to 2030, driven by rising East Asian herbal-self-care and post-pandemic immunity awareness. Yet competitive intensity is moderate–high: 30-plus domestic brands in China/Korea plus two EU-GMP entrants keep gross margins under 35 %. Consolidation is likely as top-five players scale e-pharmacy DTC sales and lock in cultivated Houttuynia supply through forward contracts.

Long-term, the segment will bifurcate into standardised extract tablets (commodity) and clinically validated SKUs (premium). Innovation is concentrated in micro-encapsulation to mask fishy off-notes and co-formulation with zinc or lactoferrin for anti-viral positioning; two IND applications for adjunctive COPD therapy are in Phase II. Supply-side risks stem from weather-sensitive wild harvesting in Sichuan and Chongqing—cultivated acreage must triple by 2027 to balance demand.

Key risk factors4 items

Regulatory harmonisation on pyrrolidine alkaloid limits

Sudden TCM price floors

Consumer scepticism toward herbal antiviral claims

Currency swings in won/yen export markets

12 items

1. Executive Summary

2. Houttuynia Cordata Sodium Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Houttuynia Cordata Sodium Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Houttuynia Cordata Sodium Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Houttuynia Cordata Sodium Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Houttuynia Cordata Sodium Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Houttuynia Cordata Sodium Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Houttuynia Cordata Sodium Tablets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Houttuynia Cordata Sodium Tablets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Houttuynia Cordata Sodium Tablets Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Houttuynia Cordata Sodium Tablets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Houttuynia Cordata Sodium Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Houttuynia Cordata Sodium Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Houttuynia Cordata Sodium Tablets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Houttuynia Cordata Sodium Tablets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Houttuynia Cordata Sodium Tablets Market Competition by Key Manufacturers

9.1. Global Houttuynia Cordata Sodium Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Houttuynia Cordata Sodium Tablets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Hunan Xiangzhong Pharmaceutical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. SOUTHWESTPHARMACEUTICAL

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Beijing Saier Biological Pharmaceutical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Guangxi Tiantianle Pharmaceutical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shijiazhuang Yiling Pharmaceutical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Yunnan Phyto Pharmaceutical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Houttuynia Cordata Sodium Tablets Market

Figure 4: Global Houttuynia Cordata Sodium Tablets Market: Drivers

Figure 5: Global Houttuynia Cordata Sodium Tablets Market: Challenges

Figure 6: Global Houttuynia Cordata Sodium Tablets Market: Trends

Figure 7: Global Houttuynia Cordata Sodium Tablets Market: Opportunity

Figure 8: Global Houttuynia Cordata Sodium Tablets Market: Restraint

Figure 9: Global Houttuynia Cordata Sodium Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Houttuynia Cordata Sodium Tablets Market Value (USD Million) By Region

Figure 19: Global Houttuynia Cordata Sodium Tablets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Houttuynia Cordata Sodium Tablets Market Value (USD Million) By Region

Figure 27: Global Houttuynia Cordata Sodium Tablets Market Share (%) By: Regions (2032)

Figure 28: Global Houttuynia Cordata Sodium Tablets Market Volume (K) By Region

Figure 29: Global Houttuynia Cordata Sodium Tablets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Houttuynia Cordata Sodium Tablets Market Value (USD Million) By Region

Figure 37: Global Houttuynia Cordata Sodium Tablets Market Share (%) By: Regions (2032)

Figure 38: Global Houttuynia Cordata Sodium Tablets Market Volume (K) By Region

Figure 39: Global Houttuynia Cordata Sodium Tablets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Houttuynia Cordata Sodium Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Houttuynia Cordata Sodium Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Houttuynia Cordata Sodium Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Houttuynia Cordata Sodium Tablets Market Value (USD Million) By Region

Table 14: Global Houttuynia Cordata Sodium Tablets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Houttuynia Cordata Sodium Tablets Market Volume (K) By Region

Table 31: Global Houttuynia Cordata Sodium Tablets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Houttuynia Cordata Sodium Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Houttuynia Cordata Sodium Tablets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Houttuynia Cordata Sodium Tablets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Hunan Xiangzhong Pharmaceutical Basic Information And Sales Area

Table 52: Hunan Xiangzhong Pharmaceutical. Products Portfolio

Table 53: SOUTHWESTPHARMACEUTICAL Basic Information And Sales Area

Table 54: SOUTHWESTPHARMACEUTICAL. Products Portfolio

Table 55: Beijing Saier Biological Pharmaceutical Basic Information And Sales Area

Table 56: Beijing Saier Biological Pharmaceutical. Products Portfolio

Table 57: Guangxi Tiantianle Pharmaceutical Basic Information And Sales Area

Table 58: Guangxi Tiantianle Pharmaceutical. Products Portfolio

Table 59: Shijiazhuang Yiling Pharmaceutical Basic Information And Sales Area

Table 60: Shijiazhuang Yiling Pharmaceutical. Products Portfolio

Table 61: Yunnan Phyto Pharmaceutical Basic Information And Sales Area

Table 62: Yunnan Phyto Pharmaceutical. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Houttuynia Cordata Sodium Tablets Market Value (USD Million) By Region

Table 72: Global Houttuynia Cordata Sodium Tablets Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Houttuynia Cordata Sodium Tablets Market Volume (K) By Region

Table 89: Global Houttuynia Cordata Sodium Tablets Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Houttuynia Cordata Sodium Tablets market size?

The global Houttuynia Cordata Sodium Tablets market size crossed USD 180 million in 2023, propelled by rising demand for botanical respiratory therapeutics and post-pandemic immunity formulations.

2. What growth rate is forecast for the next five years?

Analysts project a 7.4% CAGR through 2028, driven by expanding TCM clinics, functional food crossover products, and export approvals across ASEAN markets.

3. Which factors are the primary demand drivers?

Key drivers include anti-inflammatory efficacy without antibiotics, surging pediatric respiratory cases, government TCM integration policies, and clean-label consumer trends.

4. What challenges currently constrain market expansion?

Supply-chain volatility of wild Houttuynia, inconsistent batch flavonoid levels, stringent heavy-metal limits, and limited insurance reimbursement hinder rapid scale-up.

5. Which regions dominate consumption and production?

East China and South Korea lead production; consumption hotspots are Guangdong, Zhejiang, and Vietnam, together holding 62% of 2023 volume share.

6. Who are the top companies shaping competitive dynamics?

Market leaders include Guangxi Wuzhou Pharmaceutical, Shanghai Leiyunshang, and Hanlim Pharmaceutical, collectively owning 48% share and investing in solvent-free extraction upgrades.

7. Where do future opportunities lie for new entrants?

Growth pockets exist in effervescent pediatric formats, combination SKUs with lactoferrin, and B2B nutraceutical ingredient sales to North American functional beverage brands.

8. How is technology impacting product development?

Nano-encapsulation enhances sodium houttuyfonate stability, while blockchain traceability platforms cut adulteration risks, supporting premium positioning and export premiums.

9. What does the regulatory landscape look like?

China’s new TCM Good Manufacturing Practice 2024 raises flavonoid assay thresholds; Korea classifies tablets as quasi-drugs, requiring 24-month post-marketing safety data.

10. What is the future outlook for investors?

The future outlook remains bullish—forecast to reach USD 290 million by 2029—underpinned by aging demographics, herbal antibiotic replacements, and e-pharmacy channel expansion.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Houttuynia Cordata Sodium Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	458.57 million
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hunan Xiangzhong Pharmaceutical; SOUTHWESTPHARMACEUTICAL; Beijing Saier Biological Pharmaceutical; Guangxi Tiantianle Pharmaceutical; Shijiazhuang Yiling Pharmaceutical; Yunnan Phyto Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options